EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research

Lingxuan Zhu, Zhixing Deng, Weiming Mou, Gengwen Deng, Hongyu Lu, Liling Xu, Shujia Lin, Hongsen Huang, Keren Wu, Qiheng Liang, Hao Li, Ziwen Zheng und 2 weitere

mLife · 2026-10 · 5 (5) · 531-540

DOI: 10.1002/mlf2.70107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mLife, online erschienen am 26.10.2026. Verfasst von Lingxuan Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhujiang Hospital Southern Medical University Guangzhou China. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intratumoral microbiome, as an essential component of the tumor microenvironment, has attracted increasing attention in recent years. The tumor microbiota displays an intricate interplay with its biological behaviors. However, emerging controversies, including the retraction of Poore et al.'s article, highlight significant challenges within this field. These issues extend beyond questions of reliability in this particular work to challenge fundamental theoretical assumptions and methodological validity across the entire field of tumor microbiome research, profoundly impacting its future direction. Here, we systematically summarize and discuss the current challenges and limitations in tumor microbiome research. We further propose a series of practical optimization strategies and solutions, from microbial quantification to functional experiments, providing a comprehensive framework covering the entire workflow of tumor microbiome analysis. With ongoing technical progress and standardized protocols, tumor microbiome research is poised to deliver novel insights into tumor biology and contribute to the development of improved therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

contaminationhost depletionintratumoral microbiomelow‐biomass samples

Autor:innen und Institutionen

  • Department of Oncology, Zhujiang Hospital Southern Medical University Guangzhou China.
  • Department of Urology, Shanghai General Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.
  • The First School of Clinical Medicine Southern Medical University Guangzhou China.
  • The Second School of Clinical Medicine Southern Medical University Guangzhou China.
  • Department of Microbiology, State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China.
  • Shantou University Medical College Shantou China.

ORCID-Profile: Peng Luo

Zitieren

APA

Zhu, L., Deng, Z., Mou, W., Deng, G., Lu, H., Xu, L., Lin, S., Huang, H., Wu, K., Liang, Q., Li, H., Zheng, Z., Lin, A., & Luo, P. (2026). Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research. mLife, 5(5), 531-540. https://doi.org/10.1002/mlf2.70107

Vancouver

Zhu L, Deng Z, Mou W, Deng G, Lu H, Xu L, et al. Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research. mLife. 2026;5(5):531-540. doi:10.1002/mlf2.70107

BibTeX
@article{Zhu2026,
  author = {Zhu, Lingxuan and Deng, Zhixing and Mou, Weiming and Deng, Gengwen and Lu, Hongyu and Xu, Liling and Lin, Shujia and Huang, Hongsen and Wu, Keren and Liang, Qiheng and Li, Hao and Zheng, Ziwen and Lin, Anqi and Luo, Peng},
  title = {Rethinking the tumor microbiome: Methodological challenges and a framework for rigorous research},
  journal = {mLife},
  year = {2026},
  volume = {5},
  number = {5},
  pages = {531--540},
  doi = {10.1002/mlf2.70107}
}
Kostenlos starten →